#CanTech
OCAL Financial to Present at The 2026 Cantech Investment Conference in Toronto
https://www.pressreleasecc.com/2026/10/01/ocal-financial-to-present-at-the-2026-cantech-investment-conference-in-toronto
www.pressreleasecc.com
October 3, 2026 at 9:12 PM
US tech companies have been unafraid of violating Canadian privacy laws for years. It goes back to Facebook's violations in 2009. The problem is the watchdog has no teeth. No power to fine. No power to enforce other than making a recommendation to federal court. #privacy #grok #canTech
OPC finds Grok chatbot and deepfakes violated Canada's privacy law - IAPP
An investigation by the Office of the Privacy Commissioner of Canada found X Corp. and xAI violated the country's federal private-sector privacy law by launching the Grok AI-powered image generation tool — which at one point allowed users to create and share more than 6,000 sexualized deepfake images per hour — without appropriate safeguards. In announcing the findings of the OPC's investigation into Grok, Privacy Commissioner Philippe Dufresne also called for stronger federal legislation and enforcement powers. While the OPC investigation cites statistics — including that Grok shared 1.8 million sexualized images since 29 Dec. 2025 and the Center for Countering Digital Hate's estimation that Grok generated approximately 3 million sexualized deepfakes, including 23,000 images of children, between 29 Dec. 2025 and 8 Jan. 2026 — Dufresne said the OPC lacks abilities to effectively enforce the violation of Canada's Personal Information Protection and Electronic Documents Act. "This investigation demonstrates why Canada needs modernized federal privacy laws that will better support the development of trustworthy, privacy-protective technologies," Dufresne said. Since the OPC's investigation began in January, Dufresne said X Corp. and xAI have implemented safeguards to reduce the risk of Grok's use to produce sexualized deepfakes, including a process for "anticipating...
iapp.org
June 11, 2026 at 7:54 PM
📰 #Finance

"MONTREAL, April 30, 2026 (GLOBE NEWSWIRE) — Cantech®, a leader in the pressure-sensitive tape industry and part of the IPG (Intertape Polymer Group) family, announced a strategic expansion of the iconic Tuck® Tape brand into the consumer retail market. This launch…"
Tuck Tape Expands Presence in Canadian Consumer Market with New and Rebranded Product Lineup
financialpost.com
April 30, 2026 at 4:15 PM
This analyst loves Equillium – Cantech Letter

Roth Capital Partners analyst Adam Walsh has initiated coverage of Equillium Roth Capital Partners analyst Adam Walsh initiated coverage of Equillium (Equillium Stock Quote, Chart, News, Analysts, Financials NASDAQ:EQ) with a “Buy” rating and US$12.00…
This analyst loves Equillium – Cantech Letter
Roth Capital Partners analyst Adam Walsh has initiated coverage of Equillium Roth Capital Partners analyst Adam Walsh initiated coverage of Equillium (Equillium Stock Quote, Chart, News, Analysts, Financials NASDAQ:EQ) with a “Buy” rating and US$12.00 price target, citing the potential of the company’s lead program targeting ulcerative colitis. Equillium is a biotechnology company developing therapies for severe autoimmune and inflammatory diseases.
nexttech-news.com
March 16, 2026 at 9:45 PM
This analyst loves Equillium – Cantech Letter

Roth Capital Partners analyst Adam Walsh has initiated coverage of Equillium Roth Capital Partners analyst Adam Walsh initiated coverage of Equillium (Equillium Stock Quote, Chart, News, Analysts, Financials NASDAQ:EQ) with a “Buy” rating and US$12.00…
This analyst loves Equillium – Cantech Letter
Roth Capital Partners analyst Adam Walsh has initiated coverage of Equillium Roth Capital Partners analyst Adam Walsh initiated coverage of Equillium (Equillium Stock Quote, Chart, News, Analysts, Financials NASDAQ:EQ) with a “Buy” rating and US$12.00 price target, citing the potential of the company’s lead program targeting ulcerative colitis. Equillium is a biotechnology company developing therapies for severe autoimmune and inflammatory diseases.
nexttech-news.com
March 16, 2026 at 9:44 PM
Koselugo approved in Canada for plexiform neurofibromas in adults with neurofibromatosis type 1 - Cantech Letter
Koselugo approved in Canada for plexiform neurofibromas in adults with neurofibromatosis type 1 - Cantech Letter
News update via NF Bot
news.google.com
March 16, 2026 at 2:39 PM
Sounds like an Amazing Idea

"France BANS Zoom, Microsoft, Google - Europe DETOXIFIES From USA"

We need infrastructures that are NOT US Based & will NOT collect OUR (non-US) Data!

www.youtube.com/watch?v=M2qE...

(I know the ironty of a YT link ... we NEED more options!)

#CanPoli #CanTech
France BANS American Tech Platforms - Europe DETOXIFIES From USA
YouTube video by House of El
www.youtube.com
January 29, 2026 at 10:43 AM
This analyst loves Zedcor – Cantech Letter

Ventum Capital Markets analyst Amr Ezzat has launched coverage of ZDC with a "Buy" On Dec. 11, Ventum Capital Markets analyst Amr Ezzat initiated coverage of Zedcor with a “Buy” rating and a 12-month target price of C$8.70, implying roughly 47.5% upside…
This analyst loves Zedcor – Cantech Letter
Ventum Capital Markets analyst Amr Ezzat has launched coverage of ZDC with a "Buy" On Dec. 11, Ventum Capital Markets analyst Amr Ezzat initiated coverage of Zedcor with a “Buy” rating and a 12-month target price of C$8.70, implying roughly 47.5% upside from current levels. Ezzat said the stock’s recent re-rating has pulled investor focus toward near-term estimates, while obscuring what he views as the more compelling long-duration value in the model.
nexttech-news.com
December 15, 2025 at 2:10 PM
This analyst loves Zedcor – Cantech Letter

Ventum Capital Markets analyst Amr Ezzat has launched coverage of ZDC with a "Buy" On Dec. 11, Ventum Capital Markets analyst Amr Ezzat initiated coverage of Zedcor with a “Buy” rating and a 12-month target price of C$8.70, implying roughly 47.5% upside…
This analyst loves Zedcor – Cantech Letter
Ventum Capital Markets analyst Amr Ezzat has launched coverage of ZDC with a "Buy" On Dec. 11, Ventum Capital Markets analyst Amr Ezzat initiated coverage of Zedcor with a “Buy” rating and a 12-month target price of C$8.70, implying roughly 47.5% upside from current levels. Ezzat said the stock’s recent re-rating has pulled investor focus toward near-term estimates, while obscuring what he views as the more compelling long-duration value in the model.
nexttech-news.com
December 15, 2025 at 2:10 PM
This analyst loves Extendicare – Cantech Letter

Leede Financial Group analyst Douglas Loe has raised his target to $22.75 from $16.50 Extendicare (Extendicare Stock Quote, Chart, News, Analysts, Financials TSX:EXE) is expanding its home-healthcare platform with the acquisition of peer operator CBI…
This analyst loves Extendicare – Cantech Letter
Leede Financial Group analyst Douglas Loe has raised his target to $22.75 from $16.50 Extendicare (Extendicare Stock Quote, Chart, News, Analysts, Financials TSX:EXE) is expanding its home-healthcare platform with the acquisition of peer operator CBI Health, a move Leede Financial Group analyst Douglas Loe says fits directly into the company’s strategy to concentrate on long-term care and home-care services. In a Nov.
nexttech-news.com
November 24, 2025 at 5:47 PM
This analyst loves Extendicare – Cantech Letter

Leede Financial Group analyst Douglas Loe has raised his target to $22.75 from $16.50 Extendicare (Extendicare Stock Quote, Chart, News, Analysts, Financials TSX:EXE) is expanding its home-healthcare platform with the acquisition of peer operator CBI…
This analyst loves Extendicare – Cantech Letter
Leede Financial Group analyst Douglas Loe has raised his target to $22.75 from $16.50 Extendicare (Extendicare Stock Quote, Chart, News, Analysts, Financials TSX:EXE) is expanding its home-healthcare platform with the acquisition of peer operator CBI Health, a move Leede Financial Group analyst Douglas Loe says fits directly into the company’s strategy to concentrate on long-term care and home-care services. In a Nov.
nexttech-news.com
November 24, 2025 at 5:47 PM
Will AI reshape OpenText? – Cantech Letter

National Bank of Canada Capital Markets analyst Richard Tse says OpenText is undervalued National Bank of Canada Capital Markets analyst Richard Tse says OpenText (OpenText Stock Quote, Chart, News, Analysts, Financials TSX:OTEX) is entering a pivotal…
Will AI reshape OpenText? – Cantech Letter
National Bank of Canada Capital Markets analyst Richard Tse says OpenText is undervalued National Bank of Canada Capital Markets analyst Richard Tse says OpenText (OpenText Stock Quote, Chart, News, Analysts, Financials TSX:OTEX) is entering a pivotal phase as it shifts toward AI-enabled data monetization and reshapes its portfolio through divestitures and an impending leadership transition. In a Nov. 20 update following the company’s annual OpenText World conference, Tse reiterated his “Outperform” rating and US$45 price target, saying, “Bottom line, from what we gathered, we continue to believe there’s a compelling risk-to-reward in this name.” …
nexttech-news.com
November 24, 2025 at 2:40 PM
Will AI reshape OpenText? – Cantech Letter

National Bank of Canada Capital Markets analyst Richard Tse says OpenText is undervalued National Bank of Canada Capital Markets analyst Richard Tse says OpenText (OpenText Stock Quote, Chart, News, Analysts, Financials TSX:OTEX) is entering a pivotal…
Will AI reshape OpenText? – Cantech Letter
National Bank of Canada Capital Markets analyst Richard Tse says OpenText is undervalued National Bank of Canada Capital Markets analyst Richard Tse says OpenText (OpenText Stock Quote, Chart, News, Analysts, Financials TSX:OTEX) is entering a pivotal phase as it shifts toward AI-enabled data monetization and reshapes its portfolio through divestitures and an impending leadership transition. In a Nov. 20 update following the company’s annual OpenText World conference, Tse reiterated his “Outperform” rating and US$45 price target, saying, “Bottom line, from what we gathered, we continue to believe there’s a compelling risk-to-reward in this name.” …
nexttech-news.com
November 24, 2025 at 2:40 PM